APPLICATION
ANDA075259
TYPE
ANDA
ORIGINAL APPROVAL
1998-08-27
LATEST ACTION
2002-02-21
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
DACARBAZINEPrescription
DACARBAZINE 500MG/VIAL · INJECTABLE · INJECTION
DACARBAZINEPrescription
DACARBAZINE 200MG/VIAL · INJECTABLE · INJECTION
Approval history
2002-02-21Manufacturing (CMC) · Supplement 3AP
2000-09-22Manufacturing (CMC) · Supplement 1AP
2000-09-22Labeling · Supplement 2AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.